Blog - Page 3 of 3 - InSphero
June 18, 2018

Improving preclinical models for NASH Drug Discovery

In honor of the inaugural International NASH Day, Insphero explains why we need better preclinical models for non-alcoholic steatohepatitis (NASH) disease drug discovery. Non-alcoholic fatty liver disease (NAFLD) is one of […]
May 29, 2018

AstraZeneca and Genentech publish comprehensive evaluation of 3D spheroid hepatic cultures

A landmark study comparing 2D and 3D DILI models 3D InSight™ Human Liver Microtissues is a highly predictive liver toxicology model that outperforms 2D primary human hepatocytes in culture   […]
May 28, 2018

InSphero Akura™ Flow: Transforming Drug Discovery and Development with Body-on-a-Chip Technology

InSphero Akura™ Flow body-on-a-chip technology may help make animal testing in pharma and cosmetic companies obsolete How can we better predict how new drugs act in the human body? This […]